Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin Infusion

Patient will receive a blinded infusion of oxytocin after the time of delivery of the fetus which will terminate at the time of discharge from the post-anesthesia care unit.

Trial Locations (1)

94305

Lucile Packard Children's Hospital, Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01932060 - Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery. | Biotech Hunter | Biotech Hunter